参考文献/References:
[1].Zhao D,Liu J,Wang M,et al. Epidemiology of cardiovascular disease in China:current features and implications[J]. Nat Rev Cardiol,2019,6(4):203-212.?
[2].[2] Parashar NC,Parashar G,Nayyar H,et al. N6-adenine DNA methylation demystified in eukaryotic genome:from biology to pathology[J]. Biochimie,2018,144:56-62.
[3].[3] Gan H,Hong L,Yang F,et al. Progress in epigenetic modification of mRNA and the function of m6A modification[J]. Sheng Wu Gong Cheng Xue Bao,2019,35(5):775-783.
[4].[4] Wang S,Chai P,Jia R,et al. Novel insights on m6A RNA methylation in tumorigenesis:a double-edged sword[J]. Mol Cancer,2018,17(1):101.
[5].[5] Yang Y, Hsu PJ,Chen YS,et al. Dynamic transcriptomic m6A decoration:writers,erasers,readers and functions in RNA metabolism[J]. Cell Res,2018,28(6):616-624.
[6].[6] Wen J,Lv R,Ma H,et al. Zc3h13 regulates nuclear RNA m6A methylation and mouse embryonic stem cell self-renewal[J]. Mol Cell,2018,69(6):1028-1038.
[7].[7] Zaccara S,Ries RJ,Jaffrey SR. Reading,writing and erasing mRNA methylation[J]. Nat Rev Mol Cell Biol,2019,20(10):608-624.
[8].[8] Kurmani S,Squire I. Acute heart failure:definition,classification and epidemiology[J]. Curr Heart Fail Rep,2017,14(5):385-392.
[9].[9] Dorn LE,Lasman L,Chen J,et al. The N6-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy[J]. Circulation,2019,139(4):533-545.
[10].[10] Berulava T,Buchholz E,Elerdashvili V,et al. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation[J]. Eur J Heart Fail,2020,22(1):54-66.
[11].[11] Mathiyalagan P,Adamiak M,Mayourian J,et al. FTO-dependent N6-methyladenosine regulates cardiac function during remodeling and repair[J]. Circulation,2019,139(4):518-532.
[12].[12] Slobodin B,Han R,Calderone V,et al.Transcription impacts the efficiency of mRNA translation via co-transcriptional N6-adenosine methylation[J]. Cell,2017,169(2):326-337.
[13].[13] Liu Z,Ni J,Li L,et al. SERCA2a:a key protein in the Ca2+ cycle of the heart failure[J]. Heart Fail Rev,2020,25(3):523-535.
[14].[14] Zhang B,Xu Y,Cui X,et al. Alteration of m6A RNA methylation in heart failure with preserved ejection fraction[J]. Front Cardiovasc Med,2021,8:647806.
[15].[15] Kmietczyk V,Riechert E,Kalinski L,et al. M6A-mRNA methylation regulates cardiac gene expression and cellular growth[J]. Life Sci Alliance,2019,2(2):e201800233.
[16].[16] Carnevali L,Graiani G,Rossi S,et al. Signs of cardiac autonomic imbalance and proarrhythmic remodeling in FTO deficient mice[J]. PLoS One,2014,9(4):e95499.
[17].[17] Mo XB,Lei SF,Zhang YH,et al. Detection of m6A-associated SNPs as potential functional variants for coronary artery disease[J]. Epigenomics,2018,10(10):1279-1287.
[18].[18] Guo M,Yan R,Ji Q,et al. IFN regulatory Factor-1 induced macrophage pyroptosis by modulating m6A modification of circ-0029589 in patients with acute coronary syndrome[J]. Int Immunopharmacol,2020,86:106800.
[19].[19]Zhang BY,Han L,Tang YF,et al. METTL14 regulates m6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion[J]. Eur Rev Med Pharmacol Sci,2020,24(12):7015-7023.
[20].[20]Jian D,Wang Y,Jian L,et al. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications[J]. Theranostics,2020,10(20):8939-8956.
[21].[21] Mo X,Lei S,Zhang Y,et al. Genome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci[J]. Pharmacogenomics J,2019,19(4):347-357.
[22].[22] Zheng Y,Nie P,Peng D,et al. M6AVar:a database of functional variants involved in m6A modification[J]. Nucleic Acids Res,2018,46(D1):D139-D145.
[23].[23] Song T,Yang Y,Wei H,et al. Zfp217 mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to promote adipogenic differentiation[J]. Nucleic Acids Res,2019,47(12):6130-6144.
[24].[24] Han Z,Wang X,Xu Z,et al. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1[J]. Theranostics,2021,11(6):3000-3016.
[25].[25] Yi D,Wang Q,Zhao Y,et al. Alteration of N6-methyladenosine mRNA methylation in a rat model of cerebral ischemia-reperfusion injury[J]. Front Neurosci,2021,15:605654.
[26].[26] Wang X,Wu R,Liu Y,et al. M6A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7[J]. Autophagy,2020,16(7):1221-1235.
[27].[27]Shen W,Li H,Su H,et al. FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt[J]. Mol Cell Biochem,2021,476(5):2171-2179.
[28].[28] Song H,Feng X,Zhang H,et al. METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA,which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes[J]. Autophagy,2019,15(8):1419-1437.
[29].[29] Lee SJ,Lee IK,Jeon JH. Vascular calcification—New insights into its mechanism[J]. Int J Mol Sci,2020,21(8):2685.
[30].[30] Chen J,Ning Y,Zhang H,et al. METTL14-dependent m6A regulates vascular calcification induced by indoxyl sulfate[J]. Life Sci,2019,239:117034.
[31].[31] Mo XB,Lei SF,Zhang YH,et al. Examination of the associations between m6A-associated single-nucleotide polymorphisms and blood pressure[J]. Hypertens Res,2019,42(10):1582-1589.
[32].[32] Su H,Wang G,Wu L,et al. Transcriptome-wide map of m6A circRNAs identified in a rat model of hypoxia mediated pulmonary hypertension[J]. BMC Genomics,2020,21(1):39.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(1):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(1):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(1):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(1):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(1):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(1):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]